Literature DB >> 16884490

Functional interaction of Escherichia coli heat-labile enterotoxin with blood group A-active glycoconjugates from differentiated HT29 cells.

Estela M Galván1, German A Roth, Clara G Monferran.   

Abstract

Human colon adenocarcinoma cells (HT29-ATCC) and the clone HT29-5F7 were cultured under conditions that differentiate cells to a polarized intestinal phenotype. Differentiated cells showed the presence of junctional complexes and intercellular lumina bordered by microvilli. Intestinal brush border hydrolase activities (sucrase, aminopeptidase N, lactase and maltase) were detected mainly in differentiated HT29-ATCC cells compared with the differentiated clone, HT29-5F7. The presence of non-GM1 receptors of Escherichia coli heat-labile enterotoxin (LT-I) on both types of differentiated HT29 cells was indicated by the inability of cholera toxin B subunit to block LT-I binding to the cells. Binding of LT-I to cells, when GM1 was blocked by the cholera toxin B subunit, was characterized by an increased number of LT-I receptors with respect to undifferentiated control cells. Moreover, both types of differentiated cells accumulated higher amounts of cyclic AMP in response to LT-I than undifferentiated cells. Helix pomatia lectin inhibited the binding of LT-I to cells and the subsequent production of cyclic AMP. LT-I recognized blood group A-active glycosphingolipids as functional receptors in both HT29 cell lines and the active pro-sucrase form of the glycoprotein carrying A-blood group activity present in HT29-ATCC cells. These results strongly suggest that LT-I can elicit an enhanced functional response using blood group A-active glycoconjugates as additional receptors on polarized intestinal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884490     DOI: 10.1111/j.1742-4658.2006.05368.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  6 in total

Review 1.  Structure, biological functions and applications of the AB5 toxins.

Authors:  Travis Beddoe; Adrienne W Paton; Jérôme Le Nours; Jamie Rossjohn; James C Paton
Journal:  Trends Biochem Sci       Date:  2010-03-02       Impact factor: 13.807

Review 2.  Heat-labile enterotoxin: beyond G(m1) binding.

Authors:  Benjamin Mudrak; Meta J Kuehn
Journal:  Toxins (Basel)       Date:  2010-06-14       Impact factor: 4.546

3.  Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation.

Authors:  Liang Zhao; Rongjian Su; Wenyu Cui; Yijie Shi; Liwei Liu; Chang Su
Journal:  Int J Nanomedicine       Date:  2014-05-06

4.  High-Resolution Crystal Structures Elucidate the Molecular Basis of Cholera Blood Group Dependence.

Authors:  Julie Elisabeth Heggelund; Daniel Burschowsky; Victoria Ariel Bjørnestad; Vesna Hodnik; Gregor Anderluh; Ute Krengel
Journal:  PLoS Pathog       Date:  2016-04-15       Impact factor: 6.823

5.  No direct binding of the heat-labile enterotoxin of Escherichia coli to E. coli lipopolysaccharides.

Authors:  Lena Jansson; Jonas Angström; Michael Lebens; Susann Teneberg
Journal:  Glycoconj J       Date:  2009-10-21       Impact factor: 2.916

6.  Residues of heat-labile enterotoxin involved in bacterial cell surface binding.

Authors:  Benjamin Mudrak; Daniel L Rodriguez; Meta J Kuehn
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.